Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.

Tsujikawa T, Asahi S, Oh M, Sato Y, Narita N, Makino A, Mori T, Kiyono Y, Tsuchida T, Kimura H, Fujieda S, Okazawa H.

PLoS One. 2016 May 17;11(5):e0155635. doi: 10.1371/journal.pone.0155635. eCollection 2016.

2.

Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy.

Kwon Y.

Onco Targets Ther. 2016 Apr 5;9:2007-16. doi: 10.2147/OTT.S96899. eCollection 2016. Review.

3.

Complementary therapy and survival in glioblastoma.

Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, Egan KM.

Neurooncol Pract. 2015 Sep;2(3):122-126. Epub 2015 May 6.

PMID:
26649185
4.

Vitamin E intake from natural sources and head and neck cancer risk: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.

Edefonti V, Hashibe M, Parpinel M, Ferraroni M, Turati F, Serraino D, Matsuo K, Olshan AF, Zevallos JP, Winn DM, Moysich K, Zhang ZF, Morgenstern H, Levi F, Kelsey K, McClean M, Bosetti C, Schantz S, Yu GP, Boffetta P, Chuang SC, A Lee YC, La Vecchia C, Decarli A.

Br J Cancer. 2015 Jun 30;113(1):182-92. doi: 10.1038/bjc.2015.149. Epub 2015 May 19.

5.

National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.

Lee RT, Barbo A, Lopez G, Melhem-Bertrandt A, Lin H, Olopade OI, Curlin FA.

J Clin Oncol. 2014 Dec 20;32(36):4095-101. doi: 10.1200/JCO.2014.55.8676. Epub 2014 Nov 17.

7.

PPARγ in head and neck cancer prevention.

Burotto M, Szabo E.

Oral Oncol. 2014 Oct;50(10):924-9. doi: 10.1016/j.oraloncology.2013.12.020. Epub 2014 Jan 13. Review.

8.

Commonly used methods of complementary medicine in the treatment of breast cancer.

Hübner J, Hanf V.

Breast Care (Basel). 2013 Oct;8(5):341-7. doi: 10.1159/000355705. Review.

9.

Oral premalignancy: the roles of early detection and chemoprevention.

Foy JP, Bertolus C, William WN Jr, Saintigny P.

Otolaryngol Clin North Am. 2013 Aug;46(4):579-97. doi: 10.1016/j.otc.2013.04.010. Epub 2013 May 25. Review.

10.

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS.

J Clin Oncol. 2013 Jul 10;31(20):2627-33. doi: 10.1200/JCO.2012.44.8738. Epub 2013 Jun 3.

11.

Adaptive radiation-induced epigenetic alterations mitigated by antioxidants.

Bernal AJ, Dolinoy DC, Huang D, Skaar DA, Weinhouse C, Jirtle RL.

FASEB J. 2013 Feb;27(2):665-71. doi: 10.1096/fj.12-220350. Epub 2012 Nov 1.

12.

Effect of naturopathic and nutritional supplement treatment on tumor response, control, and recurrence in patients with prostate cancer treated with radiation therapy.

Braun DP, Gupta D, Birdsall TC, Sumner M, Staren ED.

J Altern Complement Med. 2013 Mar;19(3):198-203. doi: 10.1089/acm.2011.0657. Epub 2012 Oct 4.

13.

Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer.

Smolarek AK, So JY, Burgess B, Kong AN, Reuhl K, Lin Y, Shih WJ, Li G, Lee MJ, Chen YK, Yang CS, Suh N.

Cancer Prev Res (Phila). 2012 Nov;5(11):1310-20. doi: 10.1158/1940-6207.CAPR-12-0263. Epub 2012 Sep 10.

14.

Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.

Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang CX, Saw CL, Khor TO, Kong AN, Reuhl K, Lee MJ, Yang CS, Suh N.

Mol Carcinog. 2013 Jul;52(7):514-25. doi: 10.1002/mc.21886. Epub 2012 Mar 2.

15.

Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol.

Smolarek AK, Suh N.

Nutrients. 2011 Nov;3(11):962-86. doi: 10.3390/nu3110962. Epub 2011 Nov 14. Review.

16.

Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium.

Li Q, Chuang SC, Eluf-Neto J, Menezes A, Matos E, Koifman S, Wünsch-Filho V, Fernandez L, Daudt AW, Curado MP, Winn DM, Franceschi S, Herrero R, Castellsague X, Morgenstern H, Zhang ZF, Lazarus P, Muscat J, McClean M, Kelsey KT, Hayes RB, Purdue MP, Schwartz SM, Chen C, Benhamou S, Olshan AF, Yu G, Schantz S, Ferro G, Brennan P, Boffetta P, Hashibe M.

Int J Cancer. 2012 Oct 1;131(7):1686-99. doi: 10.1002/ijc.27405. Epub 2012 Jan 27.

17.

Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.

Nakayama A, Alladin KP, Igbokwe O, White JD.

Cancer Invest. 2011 Dec;29(10):655-67. doi: 10.3109/07357907.2011.626479. Review.

18.

Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.

Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, Quesenberry CP Jr, Caan BJ.

Cancer. 2012 Apr 15;118(8):2048-58. doi: 10.1002/cncr.26526. Epub 2011 Sep 27.

19.

Mitochondrial longevity pathways.

Vendelbo MH, Nair KS.

Biochim Biophys Acta. 2011 Apr;1813(4):634-44. doi: 10.1016/j.bbamcr.2011.01.029. Epub 2011 Feb 2. Review.

20.

Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study.

Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):262-71. doi: 10.1158/1055-9965.EPI-10-1072. Epub 2010 Dec 21.

Items per page

Supplemental Content

Write to the Help Desk